FIELD: medicine.
SUBSTANCE: vitamins A and E, novocaine blocades of parotid salivary glands, intake of potassium iodide solution, intake of galantamine, additionally administered is "Vezugen" in a dose of 2 tablets (capsules) 2 times per day for 30 days are administered.
EFFECT: invention makes it possible to stimulate the formation of own saliva in patients in case of drug sialoadenopathy, conditioned by chemotherapy of malignant tumours.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING RADIAL SIALADENOPATHY | 2013 |
|
RU2572504C1 |
METHOD FOR TREATING INFLAMMATORY AND REACTIVE-DYSTROPHIC DISEASES OF MAJOR SALIVARY GLANDS | 2004 |
|
RU2290188C2 |
METHOD FOR TREATING SIALOSIS | 2004 |
|
RU2290198C2 |
METHOD TO CONDUCT PAROTID GLAND ANESTHETIZATION AND THERAPY OF PAROTITIS AND SIALOSIS | 1994 |
|
RU2071353C1 |
METHOD FOR TREATING LYMPHADENITIS, SIALADENITIS AND SIALOSIS | 1994 |
|
RU2106886C1 |
METHOD OF TREATMENT AND PREVENTION OF PTYALOLITHIASIS | 2010 |
|
RU2449752C1 |
METHOD TO TREAT SIALOSIS, CHRONIC SIALADENITIS AND SALIVARY FISTULA | 1994 |
|
RU2071318C1 |
METHOD OF TREATING SALIVOLITHIASIS | 2009 |
|
RU2398576C1 |
METHOD OF TREATMENT OF CHRONIC SIALOADENITIS | 0 |
|
SU1409291A1 |
SET OF DRUGS FOR CONDUCTING A COURSE OF TERTIARY PREVENTION OF ONCOLOGICAL DISEASES FOR IMMUNOMODULATORY EFFECTS IN COMBINATION THERAPY AND A METHOD FOR TERTIARY PREVENTION OF ONCOLOGICAL DISEASES USING COMBINATION THERAPY USING A SET OF DRUGS FOR IMMUNOMODULATING EFFECTS | 2022 |
|
RU2794024C1 |
Authors
Dates
2015-06-27—Published
2014-02-20—Filed